HI 164 in smokers with COPD

Trial Profile

HI 164 in smokers with COPD

Phase of Trial: Phase II

Latest Information Update: 20 Feb 2013

At a glance

  • Drugs HI 164 (Primary)
  • Indications Bacterial infections; Chronic obstructive pulmonary disease
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 20 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top